Author:
Hsieh Julien Wen,Landis Basile Nicolas
Publisher
Springer International Publishing
Reference32 articles.
1. Fokkens WJ, Lund VJ, Hopkins C, et al. Executive summary of EPOS 2020 including integrated care pathways. Rhinology. 2020;58:82–111.
2. Ebbens FA, Georgalas C, Rinia AB, van Drunen CM, Lund VJ, Fokkens WJ. The fungal debate: where do we stand today? Rhinology. 2007;45:178–89.
3. Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc. 1999;74:877–84.
4. Bent JP 3rd, Kuhn FA. Antifungal activity against allergic fungal sinusitis organisms. Laryngoscope. 1996;106:1331–4.
5. Wildfeuer A, Seidl HP, Paule I, Haberreiter A. In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses. 1998;41:309–19.